US Patent Issued to Regeneron Pharmaceuticals on July 18 for "Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation" (New York Inventors)

Press/Media

Period19 Jul 2023

Media coverage

1

Media coverage